Weight Management

Individuals who took probiotics during the 6-month-long study had a 27% lower overall incidence of upper respiratory tract symptoms compared to the placebo group.

Pairing semaglutide, a drug used to treat diabetes, with a minimally invasive endoscopic sleeve gastroplasty (ESG) can provide significant weight loss benefits for patients who are not candidates for invasive weight loss surgery, according to a study presented at Digestive Disease Week 2021.

Presented at the European Congress on Obesity, the analysis includes data from 121 trials with nearly 10,000 adult participants.

Obesity-related factors, including changes to the innate and adaptive immune systems brought on by excess weight, are believed to be associated with an increased risk of contracting various viral diseases.

More than half of all female patients who undergo bariatric surgery are of reproductive age, and the resulting weight loss improves fertility, as well as reducing the risk of gestational diabetes and hypertensive disorders during pregnancy.

Managing weight, blood pressure and cholesterol in children may help protect brain function later in life.

Models without the Gastrokine-1 protein weigh less and had lower levels of total body fat, despite consuming the same amount of food.

The new study evaluated data from 5000 patients with EBC and 3496 with ABC to determine associations between BMI and survival rates across both stages.

One of the first anti-obesity therapies to be introduced and marketed as a pharmaceutical was 2-4-Dinitrophenol, which entered the market around 1934.

Processed diets may initially reduce the incidence of foodborne infectious diseases, such as E.coli, but might also increase the incidence of diseases characterized by low-grade chronic infection and inflammation.

A greater understanding of obesity and its impact on cardiovascular health highlights abdominal obesity, sometimes referred to as visceral adipose tissue (VAT), as a cardiovascular disease risk marker.

Patients with COVID-19 and obesity were more likely to require oxygen and had a 73% greater change of requiring invasive mechanical ventilation.

A new study shows that overweight breast cancer survivors have a statistically significant increased risk of developing second primary cancers, and obesity is strongly associated with an increased risk of various cancer types.

Heart failure and stroke are rising among individuals below 40 years of age, with links between obesity and low fitness in the late teen years and these early diagnoses.

The researchers found that patients who reduced their calorie intake by 10% or more and adopted a moderate exercise program immediately after their diagnosis had, on average, 70% less chance of having lingering leukemia cells after a month of chemotherapy than those not on the diet-and-exercise regimen.

The study did not find significant associations between the intake of unprocessed red meat or poultry with either of these conditions, in contrast to prior studies that linked red meat to higher risks of cardiovascular disease.

The global rise of nonalcoholic fatty-liver disease in pediatric populations has highlighted the need to understand the potential cause of this growing trend.

Bariatric surgery can significantly reduce the risk of cancer—and especially obesity-related cancers—by as much as half in individuals with severe obesity and nonalcoholic fatty liver disease (NAFLD), according to a study by researchers at Rutgers Robert Wood Johnson Medical School's Center for Liver Diseases and Liver Masses.

In addition to the usual considerations of treating pediatric patients, clinicians should consider how pharmacokinetics may differ for children with obesity, according to a session at the 2021 virtual National Association of Pediatric Nurse Practitioners meeting.

Cardiometabolic health risk factors include metabolic syndrome, a cluster of disorders that include excess fat around the waist, insulin resistance, and high blood pressure.

Addressing sleep symptoms during menopause may reduce susceptibility to weight gain.

Women with obesity and polycystic ovarian syndrome (PCOS) have an increased risk of developing type 2 diabetes, according to a study presented virtually at ENDO 2021, the Endocrine Society's annual meeting.

The studies had a minimum follow-up period of 24 weeks and reported at least 1 event of breast cancer or benign breast neoplasm, which included 90,360 participants.

The STEP1 study included 1961 adults with a body mass index (BMI) of 27 or higher with at least 1 weight-related health condition, or a BMI of 30 or higher, without diabetes.

TDF-based therapy is associated with renal adverse effects (AEs) and bone loss, whereas TAF-based therapy has been associated with fewer AEs.